The president of an international health think-tank and ex professor of Harvard Med School gives an overview: what we already have, what's being developed, the pros and cons of each, the strategy for success.
A recommended read - on a large screen!
The president of an international health think-tank and ex professor of Harvard Med School gives an overview: what we already have, what's being developed, the pros and cons of each, the strategy for success.
A recommended read - on a large screen!
Thanks for the summary article which was much easier to read when I realised there was a 'full screen' option. 😀
A truly excellent analysis of where we are today and how to move forward. With one glaring defect; no mention of nasal vaccines. That is, vaccines which are administered on, in the nose, respiratory mucosa. probably 2-5 years away, possible to speed up with research money.
That benefit/ these confer "sterilizing immunity". ie. not only reduce serious illness, but prevent infection in the first place.
Absoultely where vaccination needs ot be heading.
A nasal formulation of a universal sarbecovirus vaccine is the holy grail I guess. But to be fair to the author, he didn't attempt to cover vaccines. I still like the ACE2 decoy idea, which could be delivered nasally.
The author did omit to mention the high efficacy of Remdesivir if given within 7 days of onset of symptoms.
Thanks for the information… I will put aside some time to read and digest it properly.
Take care,
Fran 😉